| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 201 | 2020 |
| Artificial intelligence and machine learning in prostate cancer patient management—current trends and future perspectives OS Tătaru, MD Vartolomei, JJ Rassweiler, O Virgil, G Lucarelli, F Porpiglia, ... Diagnostics 11 (2), 354, 2021 | 136 | 2021 |
| Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non–muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis MD Vartolomei, D Porav-Hodade, M Ferro, R Mathieu, M Abufaraj, ... Urologic Oncology: Seminars and Original Investigations 36 (9), 389-399, 2018 | 116 | 2018 |
| Radiomics in prostate cancer: An up-to-date review M Ferro, O de Cobelli, G Musi, F Del Giudice, G Carrieri, GM Busetto, ... Therapeutic Advances in Urology 14, 17562872221109020, 2022 | 98 | 2022 |
| EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU … A Horwich, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... Annals of Oncology 30 (11), 1697-1727, 2019 | 93 | 2019 |
| An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer M Ferro, MD Vartolomei, GI Russo, F Cantiello, ARA Farhan, ... World journal of urology 37, 507-514, 2019 | 93 | 2019 |
| Systemic inflammatory markers and oncologic outcomes in patients with high-risk non–muscle-invasive urothelial bladder cancer F Cantiello, GI Russo, MD Vartolomei, ARA Farhan, D Terracciano, ... European urology oncology 1 (5), 403-410, 2018 | 83 | 2018 |
| Prostate cancer radiogenomics—from imaging to molecular characterization M Ferro, O de Cobelli, MD Vartolomei, G Lucarelli, F Crocetto, B Barone, ... International Journal of Molecular Sciences 22 (18), 9971, 2021 | 75 | 2021 |
| Beyond PSA: the role of prostate health index (phi) M Ferro, O De Cobelli, G Lucarelli, A Porreca, GM Busetto, F Cantiello, ... International Journal of Molecular Sciences 21 (4), 1184, 2020 | 68 | 2020 |
| Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non–muscle-invasive bladder cancer MD Vartolomei, M Ferro, F Cantiello, G Lucarelli, S Di Stasi, R Hurle, ... Clinical Genitourinary Cancer 16 (6), 445-452, 2018 | 68 | 2018 |
| Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients MD Vartolomei, S Kimura, M Ferro, L Vartolomei, B Foerster, M Abufaraj, ... World Journal of Urology 36, 1019-1029, 2018 | 68 | 2018 |
| Reliability of frozen section examination in a large cohort of testicular masses: what did we learn? DV Matei, MD Vartolomei, G Renne, VML Tringali, A Russo, R Bianchi, ... Clinical Genitourinary Cancer 15 (4), e689-e696, 2017 | 60 | 2017 |
| Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of … M Ferro, G Di Lorenzo, MD Vartolomei, D Bruzzese, F Cantiello, ... World Journal of Urology 38, 143-150, 2020 | 59 | 2020 |
| Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients M Ferro, G Musi, A Serino, G Cozzi, FA Mistretta, B Costa, R Bianchi, ... Urologia internationalis 102 (1), 43-50, 2019 | 53 | 2019 |
| Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy MD Vartolomei, R Mathieu, V Margulis, JA Karam, M Rouprêt, I Lucca, ... World journal of urology 35, 121-130, 2017 | 53 | 2017 |
| Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: An update G Lucarelli, D Loizzo, M Ferro, M Rutigliano, MD Vartolomei, F Cantiello, ... Expert Review of Molecular Diagnostics 19 (5), 377-387, 2019 | 51 | 2019 |
| Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor M Ferro, MO Katalin, C Buonerba, R Marian, F Cantiello, G Musi, ... Urologic oncology: seminars and original investigations 38 (5), 459-464, 2020 | 49 | 2020 |
| Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy M Ferro, DF Babă, O Cobelli, G Musi, G Lucarelli, D Terracciano, ... Future Science OA 7 (7), FSO709, 2021 | 46 | 2021 |
| Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review M Ferro, F Crocetto, B Barone, F Del Giudice, M Maggi, G Lucarelli, ... Therapeutic Advances in Urology 15, 17562872231164803, 2023 | 45 | 2023 |
| Impact of age on outcomes of patients with pure carcinoma in situ of the bladder: multi-institutional cohort analysis M Ferro, S Chiujdea, G Musi, G Lucarelli, F Del Giudice, R Hurle, ... Clinical Genitourinary Cancer 20 (2), e166-e172, 2022 | 45 | 2022 |
Shahrokh F. Shariat, M.D.Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and General在 meduniwien.ac.at 的电子邮件经过验证